Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival

BACKGROUND: GP88/Progranulin is a well-recognized cell growth promoter in different cancers, and elevated serum GP88 levels have been described as negative prognostic factor in breast cancer. However, serum levels in prostate cancer (PCa) patients have not yet been studied. MATERIAL AND METHODS: We...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Manag Res
Autores principales: Greither, Thomas, Fischer, Kersten, Theil, Gerit, Marcou, Marios, Holzhausen, Hans-Juergen, Weigelt, Katrin, Serrero, Ginette, Hicks, David, Yue, Binbin, Fornara, Paolo, Wullich, Bernd, Taubert, Helge, Wach, Sven, Lieb, Verena
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6178934/
https://ncbi.nlm.nih.gov/pubmed/30323673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S172069
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares